MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0027603
Tran-Scell Biologics Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.44 Cr
▲ 1134% YoY
Net loss · FY 2025
₹1.61 Cr
Net margin -112.3%
EBITDA · FY 2025
-₹89.43 Lakh
EBITDA margin -62.3%
Authorised capital
₹3.22 Cr
Registered with MCA
Paid-up capital
₹3.14 Cr
Issued & subscribed
Satisfied charges
₹1.95 Cr
No open charges
Company age
17 yrs
Est. 2009
Directors on board
4
As per MCA filings
About Tran-Scell Biologics Private Limited
Data last updated:
Tran-Scell Biologics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the diabetes care and endocrinology clinics segment of the healthcare sector. It was incorporated on 07 December 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2009PTC066172. The company has 2 GST registrations on record, none of which is active.
The company has an authorised share capital of ₹3.22 Cr and a paid-up capital of ₹3.14 Cr. It is led by directors including Subhadra Dravida (Managing Director) and Uday Chatterjee.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.44 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.61 Cr (net margin -112.3%) and EBITDA of -₹89.43 Lakh (EBITDA margin -62.3%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 6% over five years.
Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Transcell Biosciences. As per MCA filings, the company has satisfied charges of ₹1.95 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it. The company has 8 deals on record (5 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹4.57 Cr; the latest was in September 2024.
Tran-Scell Biologics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0027603). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website transcell.in.
Company details
CIN U85100TG2009PTC066172
Registration Number 066172
Incorporation Date 07 December 2009
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0027603
CIN history
Tran-Scell Biologics has one previous CIN (Corporate Identification Number): U85100AP2009PTC066172. The current CIN is U85100TG2009PTC066172, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100TG2009PTC066172 | Current |
| U85100AP2009PTC066172 | Previous |
Recognitions & Rankings of Tran-Scell Biologics
Contact details
Tran-Scell Biologics Private Limited's registered office is in Hyderabad, Telangana. Its website is transcell.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address8th Floor Western Pearl Kondapur, Hyderabad, Telangana, India – 500084
- IndustryHealthcare, Diabetes Care & Endocrinology Clinics
To see the full contact details of Tran-Scell Biologics Private Limited, buy the company report.
Comprehensive company report
Tran-Scell Biologics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Tran-Scell Biologics operates one associated brand: Transcell Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Stem cell banking and biobanking services are provided by Transcell Biosciences. | transcell.in |
Business activity
The main business activity of Tran-Scell Biologics is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Tran-Scell Biologics Private Limited, buy the company report.
Financials of Tran-Scell Biologics Private Limited
FY 2025 filings availableTran-Scell Biologics Private Limited reported revenue of ₹1.44 Cr (up 1134% YoY) for FY 2025.
Revenue · FY 2025
₹1.44 Cr ▲ 1134%
Net loss · FY 2025
₹1.61 Cr margin -112.3%
EBITDA · FY 2025
-₹89.43 Lakh margin -62.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 27%
5 years · compounded
▼ 6%
EBITDA CAGR growth
1 year
▼ 976%
3 years · compounded
▼ 81%
5 years · compounded
▼ 36%
Revenue has declined at a compounded annual rate (CAGR) of 6% over five years. EBITDA fell 976% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹89.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.61 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -62.3% | ||||
| Net Profit Margin | -112.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tran-Scell Biologics Private Limited, buy the company report.
Board of directors of Tran-Scell Biologics Private Limited
Tran-Scell Biologics has 4 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uday Chatterjee | Director | 11 May 2020 | 6 Years 5 Months | Current |
| Vinayender Tulla | Director | 05 Oct 2015 | 11 Years 0 Months | Current |
| Subhadra Dravida Also directs: Transcell Biosciences Private Limited | Managing Director | 07 Dec 2009 | 16 Years 10 Months | Current |
| Asif Wahidul Hasan Also directs: Quantiphi Analytics Solutions Private Limited | Director | 25 Jul 2024 | 2 Years 3 Months | Current |
Auditor
Tran-Scell Biologics Private Limited is audited by Kavadapu and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kavadapu and Associates | FY 2023 | 017380S |
Shareholding
The shareholding of Tran-Scell Biologics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tran-Scell Biologics Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1.95 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jun 2012 | 10366630 | Others | ₹40 Lakh | Satisfied | |
| 21 May 2010 | 10226533 | Andhra Pradesh State Financial Corporation | ₹1.55 Cr | Satisfied |
To see the full charge records of Tran-Scell Biologics Private Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Tran-Scell Biologics Private Limited has 8 deals on record (5 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹4.57 Cr; the latest was in September 2024.
Total deals
8
Funding rounds
5
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹4.57 Cr
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2024 | Funding round | Undisclosed | Investors: Indian Angel Network, an individual |
| Mar 2016 | Funding round | ₹4.07 Cr | Investors: 4 individuals |
| Feb 2016 | Funding round | ₹6.5 Lakh | Investors: 2 individuals |
| Jan 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Foress Impex Private Limited , Shiloh Industries Private Limited |
| Jan 2015 | Secondary share transfer | Undisclosed | Buyer: Foress Impex Private Limited , Shiloh Industries Private Limited Seller: Vitae Healthcare Private Limited , an individual |
To see the full deal history of Tran-Scell Biologics Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Tran-Scell Biologics Private Limited has 2 court cases on record: 1 filed by Tran-Scell Biologics, 1 filed against it. All cases are disposed.
Total cases
2
Filed by the company
1
Filed against the company
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
| NCLT | 1 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad CCC, Telangana | Civil suit | Filed against the company by M/S Cassia Siamia Technologies Pvt. Ltd. | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Tran-Scell Biologics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tran-Scell Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Tran-Scell Biologics has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Transcell Oncologics Private Limited | U74999TG2017PTC118680 | |
| Transcell Biolife Private Limited | U74999TG2017PTC118697 |
To see the full group structure of Tran-Scell Biologics Private Limited, buy the company report.
GST
Tran-Scell Biologics has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
Total GSTINs
2
Cancelled / inactive
2
To see the full GST registrations and return filing status of Tran-Scell Biologics Private Limited, buy the company report.
Recent activity
Tran-Scell Biologics Private Limited has 18 board changes on record since 2009: 4 appointments and 14 cessations. The latest: Asif Wahidul Hasan ceased to be Additional Director on 29 Sep 2024.
AGM
Tran-Scell Biologics Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Charges
A charge registered on 22 Jun 2012 via Charge ID 10366630 with Others was fully satisfied on 20 Jun 2025.
Filing
Tran-Scell Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Asif Wahidul Hasan ceased to be Additional Director.
Appointed
Asif Wahidul Hasan was appointed as Director.
Ceased
Raviprasad Pisupati ceased to be Director.
Charges
A charge with Others of Rs. 0.40 Cr registered on 22 Jun 2012 with Charge ID 10366630 was modified on 21 Sep 2021.
Ceased
Uday Chatterjee ceased to be Additional Director.
Appointed
Uday Chatterjee was appointed as Director.
Ceased
Sanjay Vijay Singh Jesrani ceased to be Director.
Charges
A charge registered on 21 May 2010 via Charge ID 10226533 with Andhra Pradesh State Financial Corporation was fully satisfied on 28 Aug 2019.
Ceased
Dkrishna Mohan ceased to be Additional Director.
14 earlier events are in the company report.
News
Frequently asked questions
Tran-Scell Biologics is an active private limited company based in Hyderabad, Telangana, India. The company works in diabetes care and endocrinology clinics, within the healthcare industry. It was incorporated on 07 December 2009 (17+ years old) and is registered under CIN U85100TG2009PTC066172.
Tran-Scell Biologics has 4 current directors:
- Subhadra Dravida - Managing Director
- Uday Chatterjee - Director
- Vinayender Tulla - Director
- Asif Wahidul Hasan - Director
The latest financial statements of Tran-Scell Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
No. Tran-Scell Biologics has 2 GST registrations on record and all of them are cancelled or inactive.
The CIN (Corporate Identification Number) of Tran-Scell Biologics is U85100TG2009PTC066172. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tran-Scell Biologics has 2 court cases on record: 1 filed by the company and 1 filed against it. Most are in the district courts.
Tran-Scell Biologics was incorporated on 07 December 2009, making it 17+ years old. It is registered with the Registrar of Companies, Hyderabad.
Tran-Scell Biologics has 8 deals on record (5 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹4.57 Cr; the latest was in September 2024.
Asif Wahidul Hasan ceased to be Additional Director on 29 Sep 2024. Asif Wahidul Hasan was appointed as Director on 25 Jul 2024. Raviprasad Pisupati ceased to be Director on 25 Oct 2021. Tran-Scell Biologics has 18 board changes on record in total.
Yes, Tran-Scell Biologics is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0027603).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages